PBAM(PBAM)
PBAM
$89.09—Stale · unknown old
NASDAQ • Last print unknown ago
$89.09—Stale · unknown old
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $140M | $149M |
| Low | $139M | $149M |
| High | $140M | $149M |
| EBITDA Avg | $70M | $73M |
| Low | $70M | $72M |
| High | $72M | $73M |
| EBIT Avg | $69M | $71M |
| Low | $68M | $71M |
| High | $71M | $72M |
| Net Income Avg | $49M | $50M |
| Low | $48M | $50M |
| High | $50M | $51M |
| EPS Avg | $8.49 | $8.68 |
| Low | $8.31 | $8.61 |
| High | $8.60 | $8.71 |
| Analysts (Rev / EPS) | 2 / 3 | 2 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $35M | $35M | $35M | $37M | $38M | $39M |
| Low | $35M | $35M | $35M | $36M | $38M | $39M |
| High | $35M | $36M | $36M | $37M | $38M | $39M |
| EBITDA Avg | $17M | $17M | $17M | $17M | $18M | $19M |
| Low | $16M | $16M | $17M | $17M | $18M | $18M |
| High | $17M | $18M | $17M | $18M | $18M | $19M |
| EBIT Avg | $17M | $17M | $17M | $17M | $18M | $18M |
| Low | $16M | $16M | $16M | $17M | $18M | $18M |
| High | $17M | $18M | $17M | $18M | $18M | $19M |
| Net Income Avg | $12M | $12M | $12M | $12M | $13M | $13M |
| Low | $11M | $11M | $12M | $12M | $13M | $13M |
| High | $12M | $12M | $12M | $12M | $13M | $13M |
| EPS Avg | $2.07 | $2.08 | $2.05 | $2.13 | $2.22 | $2.27 |
| Low | $1.99 | $2.00 | $2.02 | $2.10 | $2.19 | $2.24 |
| High | $2.11 | $2.16 | $2.07 | $2.16 | $2.25 | $2.30 |
| Analysts (Rev / EPS) | 2 / 3 | 2 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |